Preventive Effect of Royal Jelly and 10‐HDA on Skin Damage in Diabetic Mice through Regulating Keratinocyte Wnt/β‐Catenin and Pyroptosis Pathway

Abstract

The objective of this study is to elucidate how Royal jelly (RJ) and 10‐hydroxy‐2‐decanoic acid (10‐HDA) prevents diabetic skin dysfunction by modulating the pyroptosis pathway. Type 2 diabetes models are induced by fat diet consumption and low dose of streptozotocin (STZ) in C57BL/6J mice and treated with RJ (100 mg kg–1 day–1) and 10‐HDA, the major lipid component of royal jelly (100 mg kg−1 day−1) for 28 weeks. The results show that serum concentrations of glucose and triglyceride are significantly lower in the RJ group or 10‐HDA than diabetes mellitus (DM) group. Compared to the control group, pyroptosis proteins, GSDMD, ASC, Caspase‐1, and IL‐1β are increased in the skin of the diabetic model, accompanied by the activation of the Wnt/β‐catenin signal pathway. Further evaluations by RJ exhibit superior improvement of skin damage, repress activation of the Wnt/β‐catenin pathway, and attenuate keratinocyte pyroptosis, but 10‐HDA cannot completely suppress the activation of Wnt/β‐catenin pathway and pyroptosis, which shows a relatively weak protective effect on skin damage which shows that RJ is a better effect on skin injury after DM.